Microbial patterns in acute exacerbation of chronic obstructive pulmonary disease at tertiary care
DOI:
https://doi.org/10.18203/2349-3933.ijam20241622Keywords:
Chronic obstructive pulmonary disease, Microbial pattern, Acute exacerbationAbstract
Background: In patients experiencing acute exacerbation of chronic obstructive pulmonary disease, infections represent a prevalent cause of mortality.
Methods: This study comprised a prospective cohort analysis involving 50 AECOPD patients at a tertiary care hospital located in Cumilla. The sputum culture of these patients was assessed to detect the presence of Gram-positive and Gram-negative microorganisms. Additionally, the sensitivity and resistance patterns of these microorganisms to commonly prescribed antibiotics were investigated.
Results: From January 2023 July 2023, sputum cultures of 42% of patients yielded positive results for pathogenic microorganisms. Predominantly, gram-negative organisms such as Klebsiella, Citrobacter, Pseudomonas, and Acinetobacter were isolated. The most prevalent age group among the fifty patients was 61-80 years, constituting 70% of the sample. Subsequently, the age groups of 41-60 years and 81-100 years represented 18% and 12% of the cohort, respectively. Among clinically diagnosed COPD patients experiencing acute exacerbations, 90% were male, with the majority being smokers or exposed to passive smoking. Notably, 26% of patients had a family history of COPD. Furthermore, 97% of patients had a history of respiratory infections, with 20% experiencing upper respiratory tract infections and 80% suffering from lower respiratory tract infections, including acute bronchiolitis, pneumonia, and tracheitis.
Conclusions: Klebsiella exhibited relatively high susceptibility to antibiotics such as amoxicillin, azithromycin, ciprofloxacin, and cephalosporins. Conversely, Citrobacter and Pseudomonas displayed diverse susceptibility profiles, showing varying responses to different antibiotics. Additionally, Acinetobacter demonstrated relatively lower susceptibility to several antibiotics tested, suggesting potential challenges in its management.
References
Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, Haldar P, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Resp Critical Care Med. 2011;184(6):662-71.
Molyneaux PL, Mallia P, Cox MJ, Footitt J, Willis-Owen SA, Homola D, et al. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Am J Resp Critical Care Med. 2013;188(10):1224-31.
Denner DR, Sangwan N, Becker JB, Hogarth DK, Oldham J, Castillo J, et al. Corticosteroid therapy and airflow obstruction influence the bronchial microbiome, which is distinct from that of bronchoalveolar lavage in asthmatic airways. J Aller Clin Immunol. 2016;137(5):1398-405.
Garcha DS, Thurston SJ, Patel AR, Mackay AJ, Goldring JJ, Donaldson GC, et al. Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD. Thorax. 2012;67(12):1075-80.
Sze MA, Dimitriu PA, Suzuki M, McDonough JE, Campbell JD, Brothers JF, et al. Host response to the lung microbiome in chronic obstructive pulmonary disease. Am J Resp Critical Care Med. 2015;192(4): 438-45.
Arora N, Daga MK, Mahajan R, Prakash SK, Gupta N. Chronic obstructive airway disease in a hospital based study. Indian J Chest Dis Sci. 2001;43:157-62.
Smith JA, Redman P, Woodhead MA. Antibiotic use in patients admitted with acute exacerbations of chronic obstructive pulmonary disease. Eur Resp J. 1999;13(4):835-8.
Ko FW, Ng TK, Li TS, Fok JP, Chan MC, Wu AK, et al. Sputum bacteriology in patients with acute exacerbations of COPD in Hong Kong. Resp Med. 2005;99(4):454-60.
Devanath SN. A bacteriological study of acute exacerbation of chronic obstructive pulmonary disease over a period of one year. Available at: https:// pesquisa.bvsalud.org/portal/resource/pt/sea-166781. Accessed on 20 November 2023.
Patel AK, Luhadia AS, Luhadia SK. Sputum bacteriology and antibiotic sensitivity pattern of patients having acute exacerbation of COPD in India: a preliminary study. J Pulm Resp Med. 2015;5(1):238.
Sharan H. Aerobic bacteriological study of acute exacerbations of chronic obstructive pulmonary disease. J Clin Diagn Res. 2015;9(8):DC10-2.
Suseela KV, Rennis D, Patil S, Alex A. Bacterial profile and antibiotic susceptibility in chronic obstructive pulmonary disease patients with acute exacerbation: a cross sectional study in a tertiary care hospital. Indian J Microbiol Res. 2016;3(3):317-21.
Neelamma KAS, Ragav D. Clinical profile and bacteriological eitiology in cases of acute exacerbation of COPD in a tertiary care: a tertiary care study. Int J Adv Med. 2021;8(5):696.
Mussema A, Beyene G, Gashaw M. Bacterial isolates and antibacterial resistance patterns in a patient with acute exacerbation of chronic obstructive pulmonary disease in a tertiary teaching hospital, Southwest Ethiopia. Canad J Infect Dis Med Microbiol. 2022;2022(1):9709253.
